After-hours movers: AMC Entertainment, StoneCo, Fulcrum Therapeutics, and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Morgan Stanley Reiterates Equalweight Rating on StoneCo Ltd. (STNE)
May 14, 2024 12:08 PM EDTMorgan Stanley analyst Jorge Kuri reiterated an Equalweight rating and $16.50 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "While we remain constructive on many of the primary drivers for merchant acquirers accelerating TPV growth in 2024, lower funding costs as rates... More
Citi Reiterates Buy Rating on StoneCo Ltd. (STNE)
May 14, 2024 9:56 AM EDTCiti analyst Gabriel Gusan reiterated a Buy rating and $20.00 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "We look at Stone's FIDC portfolio evolution in CVM as a proxy for credit operations. The Credit portfolio reached R$592mn in... More
BofA Securities Reiterates Underperform Rating on Fulcrum Therapeutics (FULC)
May 14, 2024 8:47 AM EDTBofA Securities analyst Tazeen Ahmad reiterated an Underperform rating and $5.00 price target on Fulcrum Therapeutics (NASDAQ: FULC).
The analyst comments "FULC announced the company has entered an exclusive license agreement with Sanofi (ticker: SNY; covered by Graham Perry) for the ex-US development of losmapimod in... More
AMC Entertainment (AMC) PT Raised to $3.20 at Citi
May 14, 2024 6:37 AM EDTCiti analyst Jason Bazinet raised the price target on AMC Entertainment (NYSE: AMC) to $3.20 (from $3.10) while maintaining a Sell rating.
The analyst comments "Maintaining Our View Following our update, our target price goes from $3.10 to $3.20. To arrive at our target... More
